20/20 Biolabs Common Stock Operating Income

Latest operating income for AIDX: $-4.7M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-1244223.00

As of Jun 30, 2026

Annual Operating Income (TTM)

$-4731750.00

Trailing 12 months ending Jun 30, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin

20/20 Biolabs Common Stock (AIDX) FAQ

As of the most recent data (June 2026), AIDX shows a operating income of $-4.7M. Scroll down for historical charts and peer comparison views.

Tracking AIDX's operating income over time shows whether 20/20 Biolabs Common Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $-4.7M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has 20/20 Biolabs Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-4.7M) with ownership activity and broader fundamentals.